Skip to Main Content


Skip Nav Destination

Bolus versus Continuous Intravenous Delivery of Doxorubicin in Soft-Tissue Sarcomas: Post Hoc Analysis of a Prospective Randomized Trial (SARC021/TH CR-406)

Clin Cancer Res (2023) 29 (6): 1068–1076.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Mei-Juan Lan
  • Di-Fei Yao
  • Ling-Ling Zhu
  • Quan Zhou
Risk Management and Healthcare Policy (2023) Volume 16: 2531.
Close Modal

or Create an Account

Close Modal
Close Modal